Case Study: a major pharma R&D strategy group improves portfolio decision-making with Evaluate’s interactive dashboard

Custom Market Outlook and Catalyst Tracking Tool for a Major Pharma R&D Strategy Group

The EvaluatePharma R&D Strategy group at a major pharmaceutical company needed to expand the reach of its specialized market data to executives who were accustomed to digital information sources. Their challenge was to make tailored market outlook and catalyst tracking information more impactful and accessible. They engaged Evaluate to address this need.

Evaluate developed a solution by creating custom analyses that integrated EvaluatePharma consensus forecasts and catalyst data. This data was aligned with the client's strategic priorities and delivered through an interactive data visualization dashboard. As a result of Evaluate's work, the client significantly improved timely access to critical information, which enabled more responsive and informed portfolio strategy decision-making.